Breaking News, Collaborations & Alliances

Asymchem Partners with LaNova Medicines

Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.

Author Image

By: Charlie Sternberg

Associate Editor

Asymchem has announced a strategic partnership agreement to provide LaNova Medicines with one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.   The collaboration between Asymchem and LaNova will include small molecule drugs, monoclonal antibodies, double antibodies, ADC projects and potentially other R&D and production initiatives. This partnership will take full advantage of Asymchem’s recently completed biological CDMO...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters